Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Elife. 2022 May 10;11:e72290. doi: 10.7554/eLife.72290.
Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental disorder caused by monoallelic mutation or deletion in the () gene. Individuals with PTHS typically present in the first year of life with developmental delay and exhibit intellectual disability, lack of speech, and motor incoordination. There are no effective treatments available for PTHS, but the root cause of the disorder, haploinsufficiency, suggests that it could be treated by normalizing gene expression. Here, we performed proof-of-concept viral gene therapy experiments using a conditional mouse model of PTHS and found that postnatally reinstating expression in neurons improved anxiety-like behavior, activity levels, innate behaviors, and memory. Postnatal reinstatement also partially corrected EEG abnormalities, which we characterized here for the first time, and the expression of key TCF4-regulated genes. Our results support a genetic normalization approach as a treatment strategy for PTHS, and possibly other TCF4-linked disorders.
皮特-霍普金斯综合征(PTHS)是一种神经发育障碍,由 ()基因的单等位基因突变或缺失引起。患有 PTHS 的个体通常在生命的第一年就表现出发育迟缓,并表现出智力残疾、语言缺失和运动不协调。目前尚无有效的治疗方法,但该疾病的根本原因——单倍剂量不足,表明通过正常化 基因表达可以进行治疗。在这里,我们使用 PTHS 的条件性 小鼠模型进行了概念验证病毒基因治疗实验,发现出生后在神经元中重新表达 改善了焦虑样行为、活动水平、本能行为和记忆。出生后重新表达也部分纠正了我们这里首次描述的 EEG 异常,以及关键的 TCF4 调节基因的表达。我们的结果支持将遗传正常化作为 PTHS 及可能的其他 TCF4 相关疾病的治疗策略。